12 million SEK to Clinical Studies Sweden to support COVID-19 studies
The six regional nodes within Clinical Studies Sweden will each receive a grant of 2 million SEK, or 12 million SEK in total, to strengthen their ability to support clinical studies linked to COVID-19.
The Swedish Research Council has been mandated by the Government to temporarily reinforce the activities within Clinical Studies Sweden to increase the opportunities for clinical researchers in Sweden to conduct clinical studies linked to the disease COVID-19.
The grants to the six regional nodes are part of the increased government funding of 100 million SEK that the Swedish Research Council, in collaboration with Vinnova, shall allocate to research and innovation that can contribute to stopping the spread of COVID-19 and preventing future pandemic outbreaks. The Swedish Research Council and Vinnova regard the investment in Clinical Studies Sweden as an important joint prioritisation.